Matloff ET - Search Results

1

Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.

Higgins SA, Matloff ET, Rimm DL, Dziura J, Haffty BG, King BL. Higgins SA, et al. Among authors: matloff et. Breast Cancer Res. 2005;7(6):R1017-22. doi: 10.1186/bcr1335. Epub 2005 Oct 24. Breast Cancer Res. 2005. PMID: 16280052 Free PMC article.

2

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.

Haffty BG, Harrold E, Khan AJ, Pathare P, Smith TE, Turner BC, Glazer PM, Ward B, Carter D, Matloff E, Bale AE, Alvarez-Franco M. Haffty BG, et al. Lancet. 2002 Apr 27;359(9316):1471-7. doi: 10.1016/S0140-6736(02)08434-9. Lancet. 2002. PMID: 11988246

3

BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations.

Turner BC, Harrold E, Matloff E, Smith T, Gumbs AA, Beinfield M, Ward B, Skolnick M, Glazer PM, Thomas A, Haffty BG. Turner BC, et al. J Clin Oncol. 1999 Oct;17(10):3017-24. doi: 10.1200/JCO.1999.17.10.3017. J Clin Oncol. 1999. PMID: 10506595

4

Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women.

Haffty BG, Silber A, Matloff E, Chung J, Lannin D. Haffty BG, et al. J Med Genet. 2006 Feb;43(2):133-7. doi: 10.1136/jmg.2005.034744. Epub 2005 Jun 27. J Med Genet. 2006. PMID: 15983021 Free PMC article.

5

Local recurrence in the conservatively treated breast cancer patient: a correlation with age and family history.

Harrold EV, Turner BC, Matloff ET, Pathare P, Beinfield M, McKhann C, Ward BA, Haffty BG. Harrold EV, et al. Among authors: matloff et. Cancer J Sci Am. 1998 Sep-Oct;4(5):302-7. Cancer J Sci Am. 1998. PMID: 9815294 Clinical Trial.

6

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups.

Haffty BG, Choi DH, Goyal S, Silber A, Ranieri K, Matloff E, Lee MH, Nissenblatt M, Toppmeyer D, Moran MS. Haffty BG, et al. Ann Oncol. 2009 Oct;20(10):1653-9. doi: 10.1093/annonc/mdp051. Epub 2009 Jun 2. Ann Oncol. 2009. PMID: 19491284 Free article.

7

A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk.

Ratner E, Lu L, Boeke M, Barnett R, Nallur S, Chin LJ, Pelletier C, Blitzblau R, Tassi R, Paranjape T, Hui P, Godwin AK, Yu H, Risch H, Rutherford T, Schwartz P, Santin A, Matloff E, Zelterman D, Slack FJ, Weidhaas JB. Ratner E, et al. Cancer Res. 2010 Aug 15;70(16):6509-15. doi: 10.1158/0008-5472.CAN-10-0689. Epub 2010 Jul 20. Cancer Res. 2010. PMID: 20647319 Free PMC article.

8

Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ.

Claus EB, Petruzella S, Matloff E, Carter D. Claus EB, et al. JAMA. 2005 Feb 23;293(8):964-9. doi: 10.1001/jama.293.8.964. JAMA. 2005. PMID: 15728167

9

Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.

Domchek SM, Friebel TM, Garber JE, Isaacs C, Matloff E, Eeles R, Evans DG, Rubinstein W, Singer CF, Rubin S, Lynch HT, Daly MB, Weitzel J, Ganz PA, Pichert G, Olopade OI, Tomlinson G, Tung N, Blum JL, Couch F, Rebbeck TR. Domchek SM, et al. Breast Cancer Res Treat. 2010 Nov;124(1):195-203. doi: 10.1007/s10549-010-0799-x. Epub 2010 Feb 24. Breast Cancer Res Treat. 2010. PMID: 20180014 Free PMC article.

10

The breast surgeon's role in BRCA1 and BRCA2 testing.

Matloff ET. Matloff ET. Am J Surg. 2000 Oct;180(4):294-8. doi: 10.1016/s0002-9610(00)00460-8. Am J Surg. 2000. PMID: 11113439 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page